W
Werner Hohenberger
Researcher at University of Erlangen-Nuremberg
Publications - 607
Citations - 29806
Werner Hohenberger is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Colorectal cancer & Cancer. The author has an hindex of 68, co-authored 603 publications receiving 26708 citations.
Papers
More filters
Journal ArticleDOI
Sacral nerve stimulation in the treatment of faecal incontinence
TL;DR: All patients suffered from incontinence for liquid and solid stool due to a functional deficit of the morphologically intact anal sphincter, and underwent operative implantation of a permanent neurostimulation device.
Journal ArticleDOI
Lymph node dissection for clinically evident lymph node metastases of malignant melanoma.
TL;DR: TLND is worthwhile and offers a potential chance of cure in about one-third of melanoma patients with established regional lymph node metastases, and there are subgroups with a particularly poor prognosis in whom the benefit of radical surgery alone is limited.
Journal ArticleDOI
Variations in the Vascular Anatomy of the Right Colon and Implications for Right-Sided Colon Surgery.
Mehmet Ayhan Kuzu,Erkin Ismail,Safa Çelik,Muhammed Feyzi Şahin,Mehmet Ali Güner,Werner Hohenberger,Halil İbrahim Açar +6 more
TL;DR: The precise vascular anatomy of the right colon according to surgical perspective is described and awareness of these complex variations may improve the quality of surgery and may prevent devastating complications during right-sided colon resections.
Journal ArticleDOI
Efficacy of surgical measures in preventing port-site recurrences in a porcine model
Claus Schneider,Andreas Jung,Marc A. Reymond,Andrea Tannapfel,J.E. Balli,Morris E. Franklin,Werner Hohenberger,Ferdinand Köckerling +7 more
TL;DR: The results strongly suggest that the quality of surgical technique has an influence on the incidence of port-site recurrences and it is proposed to use protective measures reoutinely in cancer laparoscopy.
Journal ArticleDOI
CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA)
B. Hanke,C. Riedel,S. Lampert,K. Happich,Peter Martus,H. Parsch,B. Himmler,Werner Hohenberger,Eckhart G. Hahn,Axel Wein +9 more
TL;DR: A progression can be excluded with falling levels with high diagnostic accuracy, in which CEA offers a greater degree of certainty than CA 19-9, and a confirmation of these results by multicenter trials can result in a considerable decrease of monitoring costs for palliative treatment.